Archive: 10/26/2012

Synribo approved to treat rare leukemia

(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).

Oct 26, 2012
popularity not rated yet | comments 0

Med school enrollment on rise in 2012

(HealthDay)—The number and diversity of students applying to and enrolling in medical schools in the United States increased this year, new data shows.

Oct 26, 2012
popularity 3 / 5 (1) | comments 0